NSCLC (non Small Cell Lung Cancer)

SEP 8, 2026 · OBSERVATIONAL STUDY

Real World Study of Icotinib in Adjuvant Post Surgical Treatment for Stage IA2 High Risk to IB EGFR Mutant Non Small Cell Lung Cancer

ClinicalTrials.gov

This is a registry record for a recruiting observational study with no results posted; it describes planned conduct and endpoints only, not evidence of efficacy or safety.

AUG 17, 2026 · PHASE 1/2 TRIAL

A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946

ClinicalTrials.gov

First-in-human Phase 1/2 open-label trial with planned enrollment of 201 participants; no results yet reported in this registry record.

AUG 10, 2026 · PHASE 4 TRIAL

Oral Paclitaxel Solution With Immunotherapy and Concurrent SBRT as Neoadjuvant Treatment for Older Adults With NSCLC

ClinicalTrials.gov

This is a Phase I/II trial registration with planned enrollment of 78 older adults; no results are posted, and the study is actively recruiting, making it an early-phase assessment of a novel combination.

AUG 10, 2026 · PHASE 4 TRIAL

Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors

ClinicalTrials.gov

This is a Phase 4 interventional study registration with no results posted; it describes planned pharmacokinetic endpoints in a small estimated cohort and cannot support clinical efficacy or safety conclusions.